Evidence map›Paper›PMID 40759600›Full record

ArticleJournal of child psychology and psychiatry, and allied disciplines2026

Editorial Perspective: Issues for DSM 6 - an Alternative Model for Neurodevelopmental Disorders to enhance nosological validity and clinical utility.

Michele Poletti, Antonio Preti, Andrea Raballo

Abstract readEditorial
In one paragraph

Article in Journal of child psychology and psychiatry, and allied disciplines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Michele PolettiDepartment of Mental Health and Pathological Addiction, Child and Adolescent Neuropsychiatry Service, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Antonio PretiDepartment of Neuroscience, University of Turin, Turin, Italy.
Andrea RaballoChair of Psychiatry, Faculty of Biomedical Sciences, University of Southern Switzerland, Lugano, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The categorical diagnostic approach in the DSM-5 for Neurodevelopmental Disorders often reveals significant limitations, as high rates of comorbidity are common across conditions such as ADHD, autism spectrum disorder, and developmental coordination disorder. This co-occurrence aligns with a neuroconstructive dimensional perspective of neurodevelopment, which emphasizes the interconnectedness of cognitive, motor, and social impairments evolving throughout development. This perspective challenges modular and categorical views of neurodevelopmental phenotypic manifestations. Envisioning the DSM-6, a proposed dimensional Alternative Model for Neurodevelopmental Disorders (AMND) could integrate functioning severity and pathological traits, drawing inspiration from DSM-5 innovations, such as the Autism Spectrum Disorder severity levels. Such a model could facilitate nuanced profiling of individual strengths, needs, and developmental risks, accommodating both categorical and dimensional diagnostic approaches. This framework could also improve early identification of vulnerabilities to severe mental illnesses and clarify the developmental antecedents of adult-onset psychiatric conditions, offering pragmatic insights for clinical interventions and prognosis.

Indexed as

Diagnostic and Statistical Manual of Mental DisordersNeurodevelopmental DisordersAutism Spectrum DisorderChildHumansalternative dimensional modeldimensional profiles.Neurodevelopmental disordersphenotypesseverity levels

Identifiers

PMID40759600
PMCPMC12812783

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.